200 related articles for article (PubMed ID: 19103595)
1. Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform.
Cha JY; Maddileti S; Mitin N; Harden TK; Der CJ
J Biol Chem; 2009 Mar; 284(10):6227-40. PubMed ID: 19103595
[TBL] [Abstract][Full Text] [Related]
2. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells.
Moffa AB; Ethier SP
J Cell Physiol; 2007 Mar; 210(3):720-31. PubMed ID: 17133345
[TBL] [Abstract][Full Text] [Related]
3. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.
Moffa AB; Tannheimer SL; Ethier SP
Mol Cancer Res; 2004 Nov; 2(11):643-52. PubMed ID: 15561780
[TBL] [Abstract][Full Text] [Related]
4. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis.
Cha JY; Lambert QT; Reuther GW; Der CJ
Mol Cancer Res; 2008 Mar; 6(3):435-45. PubMed ID: 18337450
[TBL] [Abstract][Full Text] [Related]
5. The role of tyrosine residues in fibroblast growth factor receptor 1 signaling in PC12 cells. Systematic site-directed mutagenesis in the endodomain.
Foehr ED; Raffioni S; Murray-Rust J; Bradshaw RA
J Biol Chem; 2001 Oct; 276(40):37529-36. PubMed ID: 11459840
[TBL] [Abstract][Full Text] [Related]
6. Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models.
Zhang H; Hylander BL; LeVea C; Repasky EA; Straubinger RM; Adjei AA; Ma WW
Br J Cancer; 2014 Jan; 110(2):320-9. PubMed ID: 24327018
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.
Bryant MR; Marta CB; Kim FS; Bansal R
Glia; 2009 Jul; 57(9):935-46. PubMed ID: 19053057
[TBL] [Abstract][Full Text] [Related]
8. Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain.
Burgar HR; Burns HD; Elsden JL; Lalioti MD; Heath JK
J Biol Chem; 2002 Feb; 277(6):4018-23. PubMed ID: 11729184
[TBL] [Abstract][Full Text] [Related]
9. Molecular networks in FGF signaling: flotillin-1 and cbl-associated protein compete for the binding to fibroblast growth factor receptor substrate 2.
Tomasovic A; Traub S; Tikkanen R
PLoS One; 2012; 7(1):e29739. PubMed ID: 22235335
[TBL] [Abstract][Full Text] [Related]
10. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.
Amann T; Bataille F; Spruss T; Dettmer K; Wild P; Liedtke C; Mühlbauer M; Kiefer P; Oefner PJ; Trautwein C; Bosserhoff AK; Hellerbrand C
Am J Pathol; 2010 Mar; 176(3):1433-42. PubMed ID: 20093481
[TBL] [Abstract][Full Text] [Related]
12. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
[TBL] [Abstract][Full Text] [Related]
13. The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling.
Mai S; Wei K; Flenniken A; Adamson SL; Rossant J; Aubin JE; Gong SG
Dev Dyn; 2010 Jun; 239(6):1888-900. PubMed ID: 20503384
[TBL] [Abstract][Full Text] [Related]
14. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.
Melillo RM; Santoro M; Ong SH; Billaud M; Fusco A; Hadari YR; Schlessinger J; Lax I
Mol Cell Biol; 2001 Jul; 21(13):4177-87. PubMed ID: 11390647
[TBL] [Abstract][Full Text] [Related]
15. Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling.
Lim YP; Low BC; Lim J; Wong ES; Guy GR
J Biol Chem; 1999 Jul; 274(27):19025-34. PubMed ID: 10383403
[TBL] [Abstract][Full Text] [Related]
16. FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway.
Zhou W; Feng X; Wu Y; Benge J; Zhang Z; Chen Z
Cell Res; 2009 Oct; 19(10):1165-77. PubMed ID: 19652666
[TBL] [Abstract][Full Text] [Related]
17. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.
Baraniak AP; Chen JR; Garcia-Blanco MA
Mol Cell Biol; 2006 Feb; 26(4):1209-22. PubMed ID: 16449636
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
Zhu X; Lee K; Asa SL; Ezzat S
Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
[TBL] [Abstract][Full Text] [Related]
19. Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase.
Parachoniak CA; Park M
J Biol Chem; 2009 Mar; 284(13):8382-94. PubMed ID: 19109251
[TBL] [Abstract][Full Text] [Related]
20. GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling.
Bai A; Meetze K; Vo NY; Kollipara S; Mazsa EK; Winston WM; Weiler S; Poling LL; Chen T; Ismail NS; Jiang J; Lerner L; Gyuris J; Weng Z
Cancer Res; 2010 Oct; 70(19):7630-9. PubMed ID: 20709759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]